Retatrutide vs Tesamorelin.
Quick Verdict
Retatrutide is a triple agonist (glp-1/gip/glucagon) primarily researched for superior body recomposition, massive fat loss, metabolic health, while Tesamorelin is a ghrh analog studied for visceral fat reduction, body recomposition.
Side-by-Side Analysis
| Dimension | Retatrutide | Tesamorelin |
|---|---|---|
| Category | Triple Agonist (GLP-1/GIP/Glucagon) | GHRH Analog |
| Mechanism | Multi-receptor activation for appetite suppression, fat oxidation, energy expenditure. | Stimulates GH for fat metabolism. |
| Half-Life | ~6 days | ~26 minutes |
| Route | SubQ | SubQ |
| Typical Dose | 2000–2000 mcg | 1000–1000 mcg |
| Frequency | 1x/wk | 7x/week |
| Evidence Level | Strong | Very Strong |
| Indexed Studies | 20+ indexed | 20+ indexed |
| FDA Status | Approved | Approved |
| Lowest Price | $69.99 / 10mg via Amino Club | $69.99 / 10mg via Amino Club |
| Per-mg Cost | $7.00/mg | $7.00/mg |
Mechanism of Action Comparison
How Retatrutide Works
Retatrutide Retatrutide is an investigational triple GLP-1/GIP/glucagon receptor agonist studied in Phase 2 trials, producing the highest weight loss ever recorded in an obesity drug trial at 24%.
Multi-receptor activation for appetite suppression, fat oxidation, energy expenditure. Unique triple agonism at GLP-1, GIP, and glucagon receptors delivers synergistic metabolic effects unmatched by single or dual agonists.
How Tesamorelin Works
Tesamorelin Tesamorelin is the only FDA-approved growth-hormone-releasing peptide (Egrifta) indicated specifically for reducing visceral abdominal fat in HIV-associated lipodystrophy.
Stimulates GH for fat metabolism. Binds to GHRH receptors on the pituitary gland to stimulate natural growth hormone production, specifically targeting visceral adipose tissue.
Key Mechanistic Difference
Retatrutide operates as a triple agonist (glp-1/gip/glucagon), while Tesamorelin functions as a ghrh analog — these are fundamentally different pharmacological approaches. Retatrutide has a significantly longer half-life (~6 days) compared to Tesamorelin (~26 minutes), which impacts dosing frequency and sustained activity.
Research Evidence
Retatrutide
20 studies- Retatrutide Phase 2 trial: ~24% weight loss at 48 weeksJastreboff et al. (NEJM): Phase 2 RCT showing 24.2% body weight reduction at 12mg dose over 48 weeks the highest repor…Strong
- Retatrutide Phase 1 safety and dose-dependent weight lossFirst-in-human Phase 1 trial demonstrating dose-dependent weight loss, favorable safety profile, and significant HbA1c r…Moderate
- Retatrutide reduces liver fat (MASLD Phase 2a sub-study)Randomized Phase 2a sub-study (n=98, Nature Medicine 2024): retatrutide 12mg achieved 82.4% relative liver fat reduction…Strong
Tesamorelin
20 studies- Tesamorelin visceral fat reduction (FDA trial)Falutz et al. (JAMA): Randomized, double-blind, placebo-controlled Phase 3 trial showing 15.2% reduction in visceral adi…Very Strong
- Tesamorelin 52-week extension study sustained VAT reductionFalutz et al. (J. Clin. Endocrinol. Metab.): 52-week data confirming sustained 18% visceral fat reduction with continuou…Strong
- Tesamorelin reduces liver fat in HIV lipodystrophyStanley et al. (Ann. Intern. Med.): RCT demonstrating tesamorelin reduces hepatic fat content in HIV-infected patients w…Strong
Vendor Pricing
· Affiliate links · Prices verified 2026Retatrutide
1 vendorAffiliate disclosure: PeptiDex may earn a commission from purchases via vendor links at no extra cost to you. See our methodology.
Frequently Asked Questions
Can I take Retatrutide and Tesamorelin together?▼
No direct interaction data is available for this specific pair. They target different receptor systems, suggesting they could potentially be combined, but no published protocol validates this combination.
Which has more research evidence — Retatrutide or Tesamorelin?▼
Retatrutide has 20 indexed studies (highest evidence: Strong). Tesamorelin has 20 indexed studies (highest evidence: Very Strong). Both have comparable research coverage.
What is the price difference between Retatrutide and Tesamorelin?▼
At current verified vendor prices, Tesamorelin starts at $7.00/mg while Retatrutide starts at $7.00/mg. Prices vary by vendor and vial size — see the full vendor comparison below.
Which is better for fat loss — Retatrutide or Tesamorelin?▼
Both are researched for fat loss. Retatrutide addresses this via superior body recomposition, massive fat loss, metabolic health. Tesamorelin approaches it through visceral fat reduction, body recomposition. The optimal choice depends on your specific research protocol and which mechanism aligns with your objectives.
Related Comparisons
Deep Dive Profiles
Shared Research Goals
Research Use Only — Not Medical Advice
This comparison is provided for educational and research purposes only. It does not constitute medical, prescribing, or treatment advice. Clinical data cited here is sourced from published peer-reviewed trials and FDA labels. Consult a qualified healthcare professional before making any decisions about medications or research compounds. PeptiDex is an informational resource and does not sell pharmaceutical products.